Drug class
Phosphodiesterase 4 Inhibitor
11 drugs the FDA files under Phosphodiesterase 4 Inhibitor, and that we can price. Drugs in one class are not interchangeable — they share a mechanism, not a dose or a set of side effects — but the price gap between them is often large, and it is a reasonable thing to raise with a prescriber.
- 24 HR apremilast 75 MG Extended Release Oral Tablet [Otezla]Phosphodiesterase 4 Inhibitor
- apremilast 30 MG Oral Tablet [Otezla]Phosphodiesterase 4 Inhibitor
- crisaborole 0.02 MG/MG Topical Ointment [Eucrisa]Phosphodiesterase 4 Inhibitor
- roflumilast 0.25 MG Oral TabletPhosphodiesterase 4 Inhibitor
- roflumilast 0.25 MG Oral Tablet [Daliresp]Phosphodiesterase 4 Inhibitor
- roflumilast 0.5 MG Oral TabletPhosphodiesterase 4 Inhibitor
- roflumilast 0.5 MG Oral Tablet [Daliresp]Phosphodiesterase 4 Inhibitor
- roflumilast 0.5 MG/ML Topical Cream [Zoryve]Phosphodiesterase 4 Inhibitor
- roflumilast 1.5 MG/ML Topical Cream [Zoryve]Phosphodiesterase 4 Inhibitor
- roflumilast 3 MG/ML Topical Cream [Zoryve]Phosphodiesterase 4 Inhibitor
- roflumilast 3 MG/ML Topical Foam [Zoryve]Phosphodiesterase 4 Inhibitor